FluMist is the first vaccine to prevent influenza, more commonly known as the flu, that does not need to be administered by a ...

BPL-003 showed “robust” efficacy data in treatment-resistant depression, according to analysts from Jefferies, who noted that ...

People with rhinitis or sinusitis or who have chronic congestion are invited to join this 30-minute study, which is testing a novel way to decongest the nose without any medication or invasive procedu ...

ARS Pharma has claimed FDA approval for its epinephrine nasal spray neffy, becoming the first needle-free alternative to EpiPen-style autoinjectors for serious allergic reactions. The green light ...

Premature babies often need help breathing as their lungs are not fully developed. Nasal breathing support (through the nose) helps premature babies breathe without the need for breathing tubes in the ...

Positive study results in Phase 2 lead to a green light for the companies’ combination and plans to move their nasal spray ...

In a bold attempt to make your head both clearer and considerably more dystopian, scientists in China and Hong Kong have ...

AstraZeneca has failed in its bid to get US approval for its IL-5 inhibitor Fasenra as a treatment for chronic rhinosinusitis in people with nasal polyps, after the FDA rejected its marketing ...

STS101 nasal powder, DHE, delivers fast, lasting relief from cardinal migraine symptoms, including photophobia, phonophobia, ...